DAVID WEINER received the W.W. Smith Charitable Trust Professorship for Cancer Research. Weiner is executive vice president of The Wistar Institute and director of The Wistar Institute Vaccine Center. The W.W. Smith Charitable Trust is a private foundation established through the will of William Wikoff Smith. The Trust provides grants in three areas: medical research... […]
RICHARD O’REILLY was named the inaugural recipient of The Society of Memorial Sloan Kettering Prize. This new award recognizes an individual who has made outstanding contributions to the field of pediatric oncology. O’Reilly is chairman of the Department of Pediatrics and director of the Bone Marrow Transplantation Program at MSK. He pioneered the development of... […]
SEAN PARKER received the Pontifical Key Philanthropy Award at the Vatican, presented by Cardinal Gianfranco Ravasi, president of the Pontifical Council for Culture, and Robin Smith, president of the Stem for Life Foundation. This recognition was announced during The Third International Conference on the Progress of Regenerative Medicine and Its Cultural Impact, held in Vatican... […]
THE PERSHING SQUARE SOHN Cancer Research Alliance announced seven winners of the third annual Pershing Square Sohn Prize for Young Investigators in Cancer Research. Each will receive $200,000 in funding per year for up to three years. In addition to six winners funded by the alliance, a partnership with The New York Community Trust supported... […]
DOUGLAS LEVINE was named director of the Division of Gynecologic Oncology at the Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, effective May 15. Levine joins NYU Langone from Memorial Sloan Kettering Cancer Center, where he served as an attending physician and head of the Gynecology Research Laboratory. He also served as... […]
ABBVIE will acquire Stemcentrx and its lead late-stage asset rovalpituzumab tesirine (Rova-T) currently in registrational trials for small cell lung cancer. The transaction is expected to close in second-quarter of this year. Rova-T is a novel biomarker-specific therapy that is derived from cancer stem cells and targets delta-like protein 3 that is expressed in more […]
GEISINGER HEALTH SYSTEM announced that 100,000 recruits have signed up for the health system’s major biobank and DNA sequencing study known as the MyCode Community Health Initiative. Launched in January 2014 in collaboration with the Regeneron Genetics Center, the MyCode Community Health Initiative originally set out to recruit 100,000 study participants. That target, however, was […]
THE INDIANA UNIVERSITY Melvin and Bren Simon Cancer Center raised nearly $1.2 million for cancer research at its fourth annual Chuckstrong Tailgate Gala. Hosted by the Indianapolis Colts and head coach Chuck Pagano at the Indiana Farm Bureau Football Center, the gala raised the funds through corporate sponsorships, live and silent auctions, and the annual […]
ABBVIE and argenx, a clinical-stage biopharmaceutical company, will collaborate to develop and commercialize ARGX-115, Argenx’s preclinical-stage human antibody program targeting the immuno-oncology target GARP, a protein believed to contribute to immuno-suppressive effects of T-cells. “ARGX-115 has been developed in collaboration with an outstanding team of academics at the de Duve Institute / Université Catholique de […]
THE WISTAR INSTITUTE and Cormorant Pharmaceuticals AB, a Swedish biopharmaceutical company specializing in cancer drug development, formed a partnership involving Cormorant’s novel drug HuMax-IL8, which is undergoing a phase I trial at NCI. “Wistar’s biomarker analysis of the tumor samples will be instrumental in determining the effects of HuMax-IL8 on tumor immunosuppression,” said Maarten de […]
